Why the study?
Does a risk stratification score including pre-transplant cardiac troponin T (ACTV score) improve the prediction of all-cause mortality in kidney transplant recipients compared to a score without cTnT?
Does a risk stratification score including pre-transplant cardiac troponin T (ACTV score) improve the prediction of all-cause mortality in kidney transplant recipients compared to a score without cTnT?
A novel risk score (ACTV) incorporating pre-transplant cardiac troponin T, age, cardiac disease, and vascular disease effectively predicts long-term all-cause mortality in kidney transplant recipients.
Answers are grounded in this paper and cite their sources.
ACTV score may refine pre-transplant mortality risk assessment in kidney recipients; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: We evaluated the role of increased cardiac troponin T (cTnT), vascular, and cardiac diseases in predicting 5 and 10-year all-cause mortality after kidney transplantation. METHODS: We reviewed a cohort of 764 kidney transplant recipients and analyzed pertinent cardiovascular risk factors at the time of transplant evaluation. Proportional hazards regression analysis with bootstrapping method was utilized to provide a risk stratification score for mortality. RESULTS: Mean age was 58.8 years (SD 12.1) and median follow-up was 7.0 years (range 1 day to 18.0 years). Fifty-four percent of patients (n = 415) had cTnT measured (median 0.02 ng/mL, range 0.01-4.91). Fifty-three percent (n = 407) had vascular disease, 59% (n = 448) had diabetes, and 44% (n = 336) had cardiac disease pre-transplant. Sixty percent (n = 460) required dialysis. Older age, increased cTnT, pre-transplant vascular and cardiac diseases predicted mortality in multivariate analysis. We derived 2 scoring systems with and without cTnT - the ACV and ACTV scores (age, cardiac disease, elevated cTnT, and vascular disease) - as predictors of mortality after kidney transplant. Point assignments were: age 60-69 years (1), age ≥70 years (2), cardiac disease (1), cTnT ≥0.04 ng/mL (1), and vascular disease (1). Both scoring systems significantly predicted mortality. The ACTV score better delineated risk stratification across score levels (0-2, 3-4, and 5 points). CONCLUSIONS: We developed a risk schema predictive of all-cause mortality after kidney transplant in a derivation cohort. The ACTV score, including an elevated cTnT, provided superior prediction compared to a scoring system without cTnT. Further studies to validate these findings are needed.
No takes yet. Share an insight, caveat, or question.
Firth et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: